Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
SHARPS COMPLIANCE CORP (SMED)
|
Add to portfolio |
|
|
|
| Price: |
$13.79
| | Metrics |
| OS: |
19.4
|
M
| |
|
|
| Market cap: |
$268
|
M
| |
|
|
|
Net cash:
|
$23.3
|
M
| |
$1.20
|
per share
|
|
EV:
|
$245
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
$1.1
|
M
| |
228.2
|
x EV/EBIT
|
| EPS |
($0.06)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jun-30-21 | Jun-30-20 | Jun-30-19 | Jun-05-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 | Jun-30-15 |
| Revenues | 76.4 | 51.1 | 44.3 | 44.3 | 40.1 | 38.2 | 33.4 | 30.9 |
| Revenue growth | 49.4% | 15.4% | 10.4% | | 5.1% | 14.4% | 8.0% | 16.3% |
| Cost of goods sold | 47.5 | 35.4 | 31.0 | 31.0 | 28.7 | 26.4 | 22.3 | 19.9 |
| Gross profit | 28.9 | 15.8 | 13.3 | 13.3 | 11.4 | 11.8 | 11.1 | 11.0 |
| Gross margin | 37.8% | 30.8% | 29.9% | 29.9% | 28.4% | 31.0% | 33.3% | 35.6% |
| Selling, general and administrative | -47.5 | -35.4 | 12.0 | 0.0 | 11.2 | 12.2 | 10.8 | 9.5 |
| EBITA | 12.3 | 0.9 | 1.0 | 0.4 | 0.0 | -0.6 | 0.1 | 1.3 |
| EBITA margin | 16.1% | 1.8% | 2.4% | 1.0% | 0.1% | -1.5% | 0.3% | 4.3% |
| Amortization of intangibles | | | 0.6 | | 0.6 | 0.6 | 0.1 | 0.1 |
| EBIT | 12.3 | 0.9 | 0.4 | 0.4 | -0.6 | -1.2 | 0.0 | 1.2 |
| EBIT margin | 16.1% | 1.8% | 1.0% | 1.0% | -1.4% | -3.1% | 0.0% | 4.0% |
| Pre-tax income | 14.3 | 0.7 | 0.4 | 0.4 | -0.7 | -1.3 | 0.0 | 1.3 |
| Income taxes | 1.5 | -1.6 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.1 |
| Tax rate | 10.3% | | 44.3% | 44.3% | | | 64.9% | 8.8% |
| Net income | 0.0 | 0.0 | 0.2 | 0.2 | -0.7 | -1.3 | 0.0 | 1.2 |
| Net margin | 0.0% | 0.0% | 0.5% | 0.5% | -1.7% | -3.4% | 0.0% | 3.8% |
| |
| Diluted EPS | $0.00 | $0.00 | $0.01 | $0.01 | ($0.04) | ($0.08) | $0.00 | $0.07 |
| Shares outstanding (diluted) | 17.0 | 16.4 | 16.1 | 16.1 | 16.1 | 15.9 | 15.8 | 15.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|